Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation

Brain Research

Volumn 731, Issue 1-2, 1996, Pages 1-11

  Anisman, Hymie ^a   Kokkinidis, L ^c   Merali, Z ^b  

^a CARLETON UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c NONE

Author keywords

Cytokine; Dopamine; Interleukin 2; Intracranial self stimulation; Microdialysis; Psychoneuroimmunology

Indexed keywords

CYTOKINE; DOPAMINE; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; INTRAPERITONEAL DRUG ADMINISTRATION; LATERAL HYPOTHALAMUS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; REWARD; SELF STIMULATION;

EID: 0030603116     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00460-X     Document Type: Article

References (77)

1. [1] Agars, K. and Kokkinidis, L., Scopolamine increases nonreinforced behavior in an intracranial sell-stimulation discrimination paradigm, Pharmacol. Biochem. Behav., 43 (1992) 657-660.
2. 3H]dopamine in rat cultured mesencephalic cells, J. Neurochem., 61 (1993) 1284-1290.
3. [3] Anisman, H., Zalcman, S. and Zacharko, R.M., The impact of stressors on immune and central neurotransmitter activity: Bidirectional communication, Rev. Neurosci., 4 (1993) 147-180.
4. [4] Araujo, B.M., Lapchak, P.A., Collier, B. and Quirion, R., Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res., 498 (1989) 257-266.
5. [5] Banks, W.A., Kastin, A.J. and Durham, D.A., Bidirectional transport of interleukin-1 alpha across the blood-brain barrier, Brain Res. Bull., 23 (1989) 433-437.
6. [6] Bartholomew, S.A. and Huffman, S.A., Effects of peripheral cytokine injections on multiple unit activity in the anterior hypothalamic area of the mouse, Brain Behav. Immun., 7 (1993) 301-316.
7. [7] Besedovsky, H.O. and Del Rey, A., Physiological implications of the immune-neuro-endocrine network. In R. Ader, D.L. Felten and N. Cohen (Eds.), Psychoneuroimmunology. Academic Press. San Diego. 1991, pp. 589-608.
8. [8] Bielajew, C. and Shizgal, P., Behaviorally derived measures of conduction velocity for rewarding medial forebrain bundle stimulation, Brain Res., 237 (1982) 107-119.
9. [9] Bielajew, C. and Shizgal, P., Evidence implicating descending fibres in self-stimulation of the medial forebrain bundle. J. Neurosci., 6 (1986) 919-929.
10. [10] Blalock, J.E., The immune system as a sensory organ, J. Immunol., 132 (1984) 1067-1070.
11. [11] Blalock, J.E., The syntax of immune-endocrine communication, Immunol. Today, 15 (1994) 504-544.
12. [12] Bocci, V. Interleukins: Clinical pharmacokinetics and practical implications. Clin. Pharmacokinet., 21 (1991) 274-284.
13. [13] Borowski, T.B. and Kokkinidis, L., Long-term influence of damphetamine on mesolimbic brain-stimulation reward: Comparison to chronic haloperidol and naloxone effects, Pharmacol. Biochem. Behav., 43 (1992) 1-15.
14. [14] Broekkamp, C.L., Phillips, A.C. and Cools, A.R., Facilitation of self-stimulation behavior following intracerebral microinjections of opioids into the ventral tegmental area, Pharmacol. Biochem. Behav., 11 (1979) 289-295.
15. [15] Caraceni, A., Martini, C., Belli, F., Mascheroni, L., Rivoltini, L., Arienti, F. and Cascinelli, N., Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration, Eur. J. Cancer, 29A (1992) 1266-1269.
16. [16] Corbett, D. and Wise, R.A., Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: A moveable electrode mapping study, Brain Res., 185 (1980) 1-15.
17. [17] Dantzer, R. and Kelley, K.W., Stress and immunity: An integrated view of relationships between the brain and the immune system, Life Sci., 44 (1989) 1995-2008.
18. [18] Denicoff, K.D., Rubinow, D.R., Papa, M.Z., Simpson, L., Seipp, L.A., Lotze, M.T., Chang, A.E., Rosenstein, D. and Rosenberg, S.A., The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells, Ann. Int. Med., 107 (1987) 293-300.
19. [19] De Sarro, G.B., Masuda, Y., Ascioti, C., Audino, M.G. and Nistico, G., Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin-2 in rats are antagonized by naloxone, Neuropharmacology, 29 (1990) 167-179.
20. [20] Dunn, A.J., Interleukin-1 as a stimulator of hormone secretion. Prog. Neurol. Endocrinol. Immunol., 3 (1990) 26-34.
21. [21] Dunn, A.J., Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism paralleling the increased plasma corticosterone, Life Sci., 43 (1988) 429-435.
22. [22] Dunn, A.J. and Welch, J., Stress-and endotoxin-induced increases in brain tryptophan and serotonin metabolism depend on sympathetic nervous system activity, J. Neurochem., 51 (1991) 1615-1622.
23. [23] Dunn, A.J., Powell, M.L., Meitin, C. and Small, P.A., Virus infection as a stressor: Influenza virus elevates plasma concentrations of corticosterone, and brain concentrations of MHPG and tryptophan, Physiol. Behav., 45 (1989) 591-594.
24. [24] Dunn, A.J., Powell, M.L., Moreshead, W.V., Gaskin, J.M. and Hall, N.R., Effects of Newcastle disease virus administration to mice on the metabolism of cerebral biogenic amines, plasma corticosterone, and lymphocyte proliferation, Brain Behav. Immun., 1 (1987) 216-230.
25. [25] Farrar, W.L., Kilian, P.L., Ruff, M., Hill, J.M. and Pert,. C.B., Visualization and characterization of interleukin-1 receptors in brain, J. Immunol., 139 (1987) 459-463.
26. [26] Felten, D.L., Felten, S.Y., Carlson, S.L., Olschowka, J.A. and Livnat, S., Noradrenergic and peptidergic innervation of lymphoid tissue, J. Immunol., 135 (1985) 755-765.
27. [27] Fibiger, H.C. and Phillips, A.G., Mesocorticolimbic dopamine systems and reward. In: P.W. Kalivas and C.B. Nemeroff (Eds.) The Mesocorticolimbic Dopamine System, N.Y. Academy of Sciences, New York, 1988, pp. 206-215.
28. [28] Fibiger, H.C., LePiane, F.G., Jakubovic, A. and Phillips, A.G., The role of dopamine in intracranial self-stimulation of the ventral tegmental area, J. Neurosci., 1 (1987) 3888-3896.
29. [29] Hanisch, U.K., Rowe, W., Sharma, S., Meaney, M.J. and Quirion, R., Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2, Endocrinology, 135 (1994) 2465-2472.
30. [30] Hernandez, L. and Hoebel, B.G., Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens, Physiol. Behav., 44 (1988) 599-606.
31. [31] Imura, H., Fukata, J-I. and Mori, T., Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems, Clin. Endocrinol., 35 (1991) 107-115.
32. [32] Jenck, F., Gratton, A. and Wise, R.A., Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward, Brain Res., 423 (1987) 34-38.
33. [33] Kabiersch, A., Del Rey, A., Honegger, C.G. and Besedovsky, H.O., Interleukin-1 induces changes in norepinephrine metabolism in the rat brain, Brain Behav. Immun., 2 (1988) 267-274.
34. [34] Karanth, S. and McCann, S.M., Anterior pituitary hormone control by interleukin 2, Proc. Natl. Acad. Sci. USA, 88 (1991) 2961-2965.
35. [35] Katsuura, G., Gottschall, P.E. and Arimura, A., Identification of a high-affinity receptor for interleukin-1 beta in rat brain, Biochem. Biophys. Res. Commun., 156 (1988) 61-67.
36. [36] Kokkinidis, L. and McCarter, L., Postcocaine depression and sensitization of brain stimulation reward: Analysis of reinforcement and performance effects, Pharmacol. Biochem. Behav., 36 (1990) 463-471.
37. [37] Koob, G.F. and Swerdlow, N.R., The functional output of the mesolimbic dopamine system, Ann. NY Acad. Sci., 537 (1988) 216-227.
38. [38] Koob, G.F., Robledo, P., Markou, A. and Caine, S.B., The mesocorticolimbic circuit in drug dependence and reward - A role for the extended amygdala. In P.W. Kalivas and C.D. Barnes (Eds.) Limbic and Motor Circuits and Psychiatry . CRC, Boca Raton. 1993. pp. 289-309.
39. [39] Lacosta, S., Merali, Z. and Anisman, H., Cytokine-induced endocrine, neurochemical and behavioral alterations, Soc. Neurosci. Abstr., 21 (1995) 1397.
40. [40] Lacosta, S., Merali, Z., Anisman, H. and Bielajew, C., Systemic interleukin-1β and mild stress rapidly and additively increase interstitial levels of 5-HIAA and HVA at the nucleus accumbens. Soc. Neurosci. Abstr., 20 (1994) 955.
41. [41] Lacosta, S., Merali, Z., Zalcman, S. and Anisman, H., Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge, Brain Res., 664 (1994) 225-230.
42. [42] Lapchak, P.A., A role for interleukin-2 in the regulation of striatal dopaminergic function, NeuroReport, 3 (1992) 165-168.
43. [43] Lapchak, P.A., Araujo, D.M., Quirion, R. and Beaudet, A., Immunoautoradiographic localization of interleukin 2-like immunoreactivity and interleukin 2 receptors (Tac antigen-like immunoreactivity) in the rat brain, Neuroscience, 44 (1991) 173-184.
44. [44] Maness, L.M., Banks, W.A., Zadina, J.E. and Kastin, A.J., Selective transport of blood-borne interleukin-1 alpha into the posterior division of the septum of the mouse brain, Brain Res., 70 (1995) 83-88.
45. [45] Masana, M.I., Heyes, M.P. and Mefford, I.N., Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge, Prog. Neuro-Psychopharmacol. Biol. Psychiat., 14 (1990) 609-621.
46. [46] McCullough, L.D. and Salamone, J.D., Involvement of nucleus accumbens dopamine in motor activity induced by periodic food presentation: A microdialysis and behavioral study, Brain Res., 592 (1992) 29-36.
47. [47] Merrill, J.E., Interleukin-2 effects in the central nervous system, Ann. NY Acad. Sci., 594 (1990) 188-199.
48. [48] Meyers, C.A. and Valentine, A.D., Neurological and psychiatric adverse effects of immunological therapy, CNS Drugs.,3 (1995) 56-68.
49. [49] Miliaressis, E., Rompre, P.P., Laviolette, P., Philippe, L. and Coulombe, D., The curve-shift paradigm in self-stimulation. Physiol. Behav., 37 (1986) 85-91.
50. [50] Mohankumar, P.S., Thyagarajan, S. and Quadri, S.K., Interleukin-1β increases 5-hydroxyindoleacetic acid release in the hypothalamus in vivo, Brain Res. Bull., 31 (1993) 745-748.
51. [51] Mohankumar, P.S., Thyagarajan, S. and Quadri, S.K., Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from hypothalamus in vivo, Life Sci., 48 (1991) 925-930.
52. [52] Neill, D., Distinct dopamine terminals controlling behavioral activation and reward value of hypothalamic stimulation, Ann. NY Acad. Sci., 537 (1988) 520-522.
53. [53] Nistico, G., Communications among central nervous system, endocrine and immune systems: Interleukin-2, Prog. Neurobiol., 40 (1993) 463-475.
54. [54] Nistico, G. and De Sarro, G., Is interleukin-2 a neuromodulator in the brain? Trends Neurosci., 14 (1991) 146-150.
55. [55] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, New York, Academic Press, 1986.
56. [56] Phillips, A.G. and Fibiger, H.C., Anatomical and neurochemical substrates of drug reward determined by the conditioned place preference technique. In M.A. Bozarth (Ed.), Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York, 1987, pp. 275-290.
57. [57] Phillips, A.G., Jakubovic, A. and Fibiger, H.C., Increased in vivo tyrosme hydroxylase activity in rat telencephalon produced by self stimulation of the ventral tegmental area, Brain Res., 402 (1987) 109-116.
58. [58] Plata-Salaman, C.R., Immunoregulators in the nervous system, Neurosci. Biobehav. Rev., 15 (1991) 185-215.
59. [59] Puglisi-Allegra, S., Imperato, A., Angelucci, L. and Cabib, S., Acute stress induces time-dependent responses in dopamine mesolimbic system, Brain Res., 554 (1991) 217-222.
60. [60] Raber, J., Koob, G.F. and Bloom, F.E., Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signalling; Comparison with the hypothalamic response. J. Pharmacol. Exp. Ther., 272 (1995) 815-824.
61. [61] Rabin, B.S., Cohen, S., Ganguli, R., Lysle, D.T. and Cunnick, J.E., Bidirectional interaction between the central nervous system and the immune system, Crit. Rev. Immunol., 9 (1989) 279-312.
62. [62] Rivier, C., Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat, Ann. NY Acad. Sci., 697 (1993) 97-105.
63. [63] Salamone, J.D., Complex motor and sensorimotor functions of the accumbens and striatal dopamine: Involvement in instrumental behavior processes, Psychopharmacology, 107 (1992) 160-174.
64. [64] Salamone, J.D., Cousins, M.S. and Bucher, S., Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost/benefit procedure, Behav. Brain Res., 65 (1994) 221-229.
65. [65] Schmidt, E.D., Janszen, A.W.J.W., Wouterlood, F.G. and Tilders, F.J.H., Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis, J. Neurosci., 15 (1995) 7417-7426.
66. [66] Schultz, W., Apicella, P. and Ljunberg, T., Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task, J. Neurosci., 13 (1993) 900-913.
67. [67] Shintani, F., Kanba, S., Nakaki, T., Nibuya, M., Kinoshita, N., Suzuki, E., Yagi, G., Kato, R. and Asai, M., Interleukin-1β augments release of norepinephrine, dopamine and serotonin in the rat anterior hypothalamus, J. Neurosci., 13 (1993) 3574-3581.
68. [68] Shizgal, P., Bielajew, C., Corbett, D., Skelton, R. and Yeomans, J., Behavioral methods for inferring anatomical linkage between rewarding brain stimulation sites, J. Comp. Physiol. Psychol., 94 (1980) 227-237.
69. [69] Song, C., Merali, Z., Lacosta, S. and Anisman, H., Effects of cytokines and stress on neurotransmitter release in the nucleus accumbens: An in vivo microdialysis study. Psychoneuroimmunol. Res. Soc., 1996.
70. [70] Tancredi, V., Zona, C., Velotti, F., Eusebi, F. and Santoni, A., Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus, Brain Res., 525 (1990) 149-151.
71. B and NMDA receptor agonists on medial forebrain bundle self-stimulation, Behav. Brain Res, 70 (1995) in press.
72. [72] Wilson, C., Nomikos, G.G., Collu, M. and Fibiger, H.C., Dopaminergic correlates of motivated behavior: Importance of drive, J. Neurosci., 15 (1995) 5169-5178.
73. [73] Wise, R.A., Neuroleptics and operant behavior: The anhedonia hypothesis, Behav. Brain Sci., 5 (1982) 39-87.
74. [74] Wise, R.A., The anhedonia hypothesis: mark III, Behav. Brain Sci., 8 (1985) 178-186.
75. [75] Wise, R.A., Bauco, P., Carlezon, W.A. and Trojniar, W., Self-stimulation and drug reward mechanisms, Ann. NY Acad. Sci., 654 (1994) 192-198.
76. [76] Zacharko, R.M., Bowers, W.J., Kokkinidis, L. and Anisman, H., Region specific reductions of intracranial self-stimulation after uncontrollable stress: Possible effects on reward processes, Behav. Brain Res., 9 (1983) 129-141.
77. [77] Zalcman, S., Green-Johnson, J., Murray, L., Nance, D.M., Dyck, D., Anisman, H. and Greenberg, A., Cytokine-specific central monoamine alterations induced by interleukin (IL)-1, IL-2 and IL-6, Brain Res., 643 (1994) 40-99.